Literature DB >> 10094399

Protein kinase CK2 interacts with a multi-protein binding domain of p53.

C Götz1, P Scholtes, A Prowald, N Schuster, W Nastainczyk, M Montenarh.   

Abstract

p53 is one of the most powerful negative regulators of growth. To manage this in an efficient way it has to interact with a set of different cellular proteins. Most contacts with the cellular environment occur in the N- or the C-terminal domain of the protein. Since we previously found that p53 binds to the regulatory beta-subunit of CK2 we now analyzed N- and C-terminal domains of p53 separately for the binding of protein kinase CK2, an enzyme which seems to have a certain importance for proliferation processes. With different overlay assays we could map the binding domain of protein kinase CK2 to a sequence between amino acids 325-344, a region which coincides with the interaction domain of some other p53 binding proteins. We also found that the regulatory beta-subunit of protein kinase CK2 binds independent of the catalytic alpha-subunit to this C-terminal domain of p53.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094399

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  51 in total

1.  The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function.

Authors:  M Nevels; S Rubenwolf; T Spruss; H Wolf; T Dobner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

2.  Protein kinase activity associated with immunopurified p53 protein.

Authors:  S Kraiss; A Barnekow; M Montenarh
Journal:  Oncogene       Date:  1990-06       Impact factor: 9.867

3.  The in vitro phosphorylation of p53 by calcium-dependent protein kinase C--characterization of a protein-kinase-C-binding site on p53.

Authors:  C Delphin; K P Huang; C Scotto; A Chapel; M Vincon; E Chambaz; J Garin; J Baudier
Journal:  Eur J Biochem       Date:  1997-05-01

4.  Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory beta-subunit of protein kinase CK2.

Authors:  K Appel; P Wagner; B Boldyreff; O G Issinger; M Montenarh
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

5.  Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53.

Authors:  P R Yew; X Liu; A J Berk
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

Review 6.  p53: DNA damage, DNA repair, and apoptosis.

Authors:  C Götz; M Montenarh
Journal:  Rev Physiol Biochem Pharmacol       Date:  1996       Impact factor: 5.545

7.  p53 domains: identification and characterization of two autonomous DNA-binding regions.

Authors:  Y Wang; M Reed; P Wang; J E Stenger; G Mayr; M E Anderson; J F Schwedes; P Tegtmeyer
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

8.  p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain.

Authors:  G Bakalkin; G Selivanova; T Yakovleva; E Kiseleva; E Kashuba; K P Magnusson; L Szekely; G Klein; L Terenius; K G Wiman
Journal:  Nucleic Acids Res       Date:  1995-02-11       Impact factor: 16.971

9.  Isolation and characterization of a monoclonal anti-protein kinase CK2 beta-subunit antibody of the IgG class for the direct detection of CK2 beta-subunit in tissue cultures of various mammalian species and human tumors.

Authors:  W Nastainczyk; I Schmidt-Spaniol; B Boldyreff; O G Issinger
Journal:  Hybridoma       Date:  1995-08

10.  Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor.

Authors:  T Dobner; N Horikoshi; S Rubenwolf; T Shenk
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

View more
  8 in total

1.  Knocking out the regulatory beta subunit of protein kinase CK2 in mice: gene dosage effects in ES cells and embryos.

Authors:  Olivier Blond; Hans H Jensen; Thierry Buchou; Claude Cochet; Olaf-Georg Issinger; Brigitte Boldyreff
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

2.  Contribution of the individual subunits of protein kinase CK2 and of hPrp3p to the splicing process.

Authors:  Janka Dörr; Sabine Kartarius; Claudia Götz; Mathias Montenarh
Journal:  Mol Cell Biochem       Date:  2008-06-14       Impact factor: 3.396

3.  Evidence for allosteric effects on p53 oligomerization induced by phosphorylation.

Authors:  Petr Muller; Juliana M Chan; Oliver Simoncik; Miroslav Fojta; David P Lane; Ted Hupp; Borivoj Vojtesek
Journal:  Protein Sci       Date:  2017-12-08       Impact factor: 6.725

4.  Ability of CK2beta to selectively regulate cellular protein kinases.

Authors:  Birgitte B Olsen; Barbara Guerra
Journal:  Mol Cell Biochem       Date:  2008-06-17       Impact factor: 3.396

5.  Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation.

Authors:  Zehavit Goldberg; Ronit Vogt Sionov; Michael Berger; Yaara Zwang; Ruth Perets; Richard A Van Etten; Moshe Oren; Yoichi Taya; Ygal Haupt
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

6.  Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.

Authors:  Sárka Pospísilová; Václav Brázda; Katerina Kucharíková; M Gloria Luciani; Ted R Hupp; Petr Skládal; Emil Palecek; Borivoj Vojtesek
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

7.  Specific recognition of p53 tetramers by peptides derived from p53 interacting proteins.

Authors:  Ronen Gabizon; Tobias Brandt; Shahar Sukenik; Noa Lahav; Mario Lebendiker; Deborah E Shalev; Dmitry Veprintsev; Assaf Friedler
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

Review 8.  Allosteric modulation of protein oligomerization: an emerging approach to drug design.

Authors:  Ronen Gabizon; Assaf Friedler
Journal:  Front Chem       Date:  2014-03-24       Impact factor: 5.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.